METASTATIC NSCLC
Clinical trials for METASTATIC NSCLC explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NSCLC trials appear
Sign up with your email to follow new studies for METASTATIC NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lung cancer: experimental drug combo enters final testing phase
Disease control TerminatedThis study tests whether adding an experimental drug called nogapendekin alfa inbakicept (NAI) to standard chemotherapy and immunotherapy can help people with advanced non-small cell lung cancer live longer without their cancer growing. About 494 adults with stage IV lung cancer …
Matched conditions: METASTATIC NSCLC
Phase: PHASE3 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New combo therapy aims to boost immune attack on hard-to-treat cancers
Disease control OngoingThis early-phase study tests a new drug called NBTXR3, which is injected into tumors and activated by radiation. It is combined with an immunotherapy (anti-PD-1) to see if it can help the immune system fight advanced cancers better. The study involves about 145 people with variou…
Matched conditions: METASTATIC NSCLC
Phase: PHASE1 • Sponsor: Nanobiotix • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Blood tests could reveal who benefits from immunotherapy
Knowledge-focused OngoingThis study looks at how well immunotherapy works in people with advanced lung or head and neck cancers. Researchers will take blood samples before and after treatment to measure how the body clears the drug and how tumor cells in the blood change. The goal is to find markers that…
Matched conditions: METASTATIC NSCLC
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:10 UTC